secwatch.observer — SEC 8-K summary
======================================

Issuer:     GT Biopharma, Inc. (GTBP)
CIK:        0000109657
Form:       8-K
Filed at:   2025-11-26T23:59:59+00:00
Accession:  0001493152-25-025162
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

GT Biopharma receives Nasdaq delisting notice for low bid price
---------------------------------------------------------------

- Nasdaq notified GT Biopharma on Nov 20, 2025 that stock closed below $1 for 30 consecutive days, violating Minimum Bid Price Requirement.
- Company has 180 calendar days until May 19, 2026 to regain compliance by closing at $1 for at least 10 consecutive business days.
- If not cured, may qualify for additional 180-day period if it meets other listing standards and notifies Nasdaq of intent to reverse split.
- Company says it will monitor bid price and assess options; no assurance compliance will be regained.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/109657/000149315225025162/0001493152-25-025162-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/109657/000149315225025162/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-025162

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer